Concepedia

Yanke Liang

YL

24

Publications

3K

Citations

19

H-Index

2004

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Whitehead Institute for Biomedical Research

Chinese Academy of Sciences

Massachusetts General Hospital

Yanke Liang is an author at Dana-Farber Cancer Institute specializing in medicine, natural sciences, and pharmacology.

Top concepts

MedicineNatural SciencesPharmacologyCell SignalingChemical BiologyMolecular BiologySignal TransductionChemistryEngineeringBiochemistry

Publications per year

2004–2022

24

Publications

24

Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation

Baishan Jiang, Michael A. Erb, Yanke Liang et al. · Nature Chemical Biology · 2017 · 531 citations · Full text

Selective Cdk9 Inhibition, Medicine, Receptor Tyrosine Kinase +4

Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors

Tinghu Zhang, Nicholas Kwiatkowski, Sarah E. Dixon-Clarke et al. · Nature Chemical Biology · 2016 · 356 citations · Full text

Drug Target, Drug Targeting, Biochemistry +10

Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development

Katherine A. Donovan, Fleur M. Ferguson, Jonathan W. Bushman et al. · Cell · 2020 · 346 citations · Full text

Geometric Modeling, Robotics, Engineering +11

Development of Dual and Selective Degraders of Cyclin‐Dependent Kinases 4 and 6

Baishan Jiang, Eric S. Wang, Katherine A. Donovan et al. · Angewandte Chemie International Edition · 2019 · 253 citations · Full text

Chemoprevention Strategy, Molecular Regulation, Molecular Biology +20

Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML

Matthias Brand, Baishan Jiang, Sophie Bauer et al. · Cell chemical biology · 2018 · 244 citations · Full text

Natural Sciences, Molecular Biology, Homolog-selective Degradation +2

Rows per page

1–5 of 24